The Complexities of CD28 and CTLA-4 Signalling: PI3K and Beyond

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 2, 1999, Pages 69-75

  Ward, Stephen G ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

Author keywords

CD28; CTLA 4; PI3K; Signalling; T cell

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; HUMANS; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0032619557     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. AUGUST A., GIBSON S., KAWAKAMI Y., KAWAKAMI T., MILLS G. B. and DUPONT B. (1994): CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukaemic T cell line. Proc. Natl. Acad. Sci. USA, 91, 9347-9351.
2. BOISE L. H., MINN A. J., NOEL P. J., JUNE C. H., ACCAVITTI M. A., LINDSTEN T. and THOMPSON C. B. (1995): CD28 costimulation can prómote T cell survival by enhancing the expression of Bcl-xL. Immunity, 3, 87-98.
3. BRENNAN P., BABBAGE J., BURGERING B. M. T., GRONER B., REIF K. and CANTRELL D. A. (1997): PI3K couples IL-2 receptor to the cell cycle regulator E2F. Immunity, 7, 679-689.
4. BRETSCHER J. F. and COHN M. (1970): A theory of self-nonself discrimination. Science, 169, 1042-1046.
5. BURGERING B. M. T. and COFFER P. J. (1995): Protein kinase B (c-Akt) in PI3K signal transduction. Nature, 376, 599-602.
6. + T cells. Science, 276, 273-276.
7. CEFAI D., SCHNEIDER H., MATANGKASOMBUT O., KANG H., BRODY J. and RUDD C. E. (1998): CD28 receptor endocytosis is targeted by mutations that disrupt PI3K binding and costimulation. J. Immunol., 160, 2223-2230.
8. CERDAN C., MARTIN Y., COURCOUL M., BRAILLY H., MAWAS C., BIRG F. and OLIVE D. (1992): Prolonged IL-2Rα/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. J. Immunol., 149, 2255-2261.
9. CHAMBERS C. A., KRUMMEL M. F., BOITEL B., HURWITZ A., SULLIVAN T. J., FOURNIER S., CASSELL D., BRUNNER M. and ALLISON J. P. (1996): Role of CTLA-4 in the regulation and initiation of T cell responses. Immunol. Rev., 153, 27-46.
10. DATTA S. R., DUDEK H., TAO X., MASTERS S., FU H., GOTOH Y. and GREENBERG M. E. (1997): Akt phosphorylation of BAD coupled survival signals to the cell-intrinsic death machinary. Cell, 91, 231-241.
11. EDMEAD C., PATEL Y. I., WILSON A., BOULOUGOURIS G., HALL N. D., WARD S. G. and SANSOM D. M. (1996): Induction of AP-1 and NFκB by CD28 stimulation involves both PI3K and acidic sphingomyelinase signals. J. Immunol., 157, 3290-3297.
12. GUINAN E. C., GRIBBEN J. G., BOUSSIOTIS V. A., FREEMAN G. J. and NADLER L. M. (1994): Pivotal role of the B7: CD28 pathway in transplantation, tolerance and tumor immunity. Blood, 84, 3261-3282.
13. HAN J., LUBY-PHELPS K., DAS B., SHU X., XIA Y., MOSTELLER R. D., KRISHNA M., FALCK J. R., WHITE M. and BROEK D. (1998): Role of substrates and products of PI3K in regulating activation of Rac-related guanosine trisphosphatases by Vav. Science, 279, 558-561.
14. JOLY M., KAZLAUSKAS A., FAY F. and CORVERA S. (1994): Disruption of PDGF receptor trafficking by mutation of its PI3K binding sites. Science, 263, 684-687.
15. JUNE C. H., BLUESTONE J. A., NADLER L. M. and THOMPSON C. B. (1994): The B7 and CD28 receptor families. Immunol. Today, 15, 321-332.
16. KAGA S., RAGG S., ROGERS K. A. and OCHI A. (1998): Activation of p21-Cdc42/Rac-activated kinases by CD28 signalling: p21-activated kinase (PAK) and MEK kinase 1 (MEKK1) may mediate the interplay between CD3 and CD28 signals. J. Immunol., 160, 4182-4189.
17. KING P. D., SADRA A., TENG J. M., LIU X. R., HAN A., SELVAKUMAR A., AUGUST A. and DUPONT B. (1997): Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases EMT and Lck. J. Immunol., 158, 580-590.
18. KLASEN S., PAGES F., PEYRON J. F., CANTRELL D. A. and OLIVE D. (1998): Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int. Immunol., 10, 481-489.
19. KYRIAKIS J. M. and AVRUCH J. (1996): Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays, 18, 567-577.
20. LENSCHOW D. J., WALUNAS T. L. and BLUESTONE J. A. (1996): CD28/B7 system of T cell costimulation. Ann. Rev. Immunol., 14, 233-250.
21. LEUNG H. T., BRADSHAW J., CLEVELAND J. S. and LINSLEY P. S. (1995): CTLA-4, a high avidity receptor for CD80 and CD86 contains a intracellular localisation motif in its cytoplasmic tail. J. Biol. Chem., 270, 25107-25114.
22. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science, 272, 1939-1943.
23. LIAO X., FOURNIER S., KILLEEN N., WEISS A., ALLISON J. P. and LITTMAN D. R. (1997): Itk negatively regulates induction of T cell proliferation by CD28 costimulation. J. Exp. Med., 186, 221-228.
24. LINSLEY P. S., BRADSHAW J., GROSMAIRE L. and LEDBEITER J. A. (1993): CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signalling. J. Immunol., 150, 3161-3169.
25. LINSLEY P. S., GREENE J. L., TAN P., BRADSHAW J., LEDBETTER J. A., ANASETTI C. and DAMLE N. K. (1992): Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med., 176, 1595-1604.
26. 2+-independent costimulatory activity. Eur. J. Immunol., 24, 2732-2739.
27. MARENGERE L. E. M., OKKENHAUG K., CLAVREUL A., COUEZ D., GIBSON S., MILLS G. B., MAK T. W. and ROTTAPEL R. (1997): The SH3 domain of ITK/EMT binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28. J. Immunol., 159, 3220-3229.
28. MARENGERE L. E. M., WATERHOUSE P., DUNCAN G. S., MITTRUCKER H. W., FENG G. S. and MAK T. W. (1996): Regulation of T cell receptor signalling by tyrosine phosphatase SYP association with CTLA-4. Science, 272, 1170-1173.
29. MARTE B. and DOWNWARD J. (1997): PKB/Akt: connecting PI3K to cell survival and beyond. Trends Biochem. Sci., 22, 355-358.
30. NISHINA H., BACHMANN M., OLIVEIRA-DOS-SANTOS A., KOZIERADZKI I., FISCHER K. D., ODERMATT B., WAKEHAM A., SHAHINIAN A., TAKIMOTO H., BERNSTEIN A., MAK T. W., WOODGETT J. R., OHASHI P. S. and PENNINGER J. M. (1997): Impaired CD28-mediated IL-2 production and proliferation in SEK1/MKK4-deficient T lymphocytes. J. Exp. Med., 186, 941-953.
31. NUNES J., TRUNEH A., OLIVE D. and CANTRELL D. A. (1996): Signal transduction by CD28 costimulatory receptor on T cells: B7.1 and B7.2 regulation of tyrosine kinase adaptor molecules. J. Biol. Chem., 271, 1591-1598.
32. PAGES F., RAGUENEAU M., ROTTAPEL R., TRUNEH A., NUNES J., IMBERT J. and OLIVE D. (1994): Binding of PI3K to CD28 is required for T cell signalling. Nature, 369, 327.
33. PARRY R. V., REIF K., SMITH G., SANSOM D., HEMMINGS B. A. and WARD S. G. (1997): Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur. J. Immunol., 27, 2495-2501.
34. PARRY R. V. and WARD S. G. (1996): Involvement of PI3K in the activation of p70S6 kinase by the T cell costimulatory molecule CD28. Biochem. Soc. Trans., 24, 88S.
35. RAAB M., CAI Y. C., BUNNELL S. C., HEYECK S., BERG L. J. and RUDD C. E. (1995): p56Lck and p59Fyn regulate CD28 binding to PI3K, Grb-2 and Itk: implications for T cell costimulation. Proc. Natl. Acad. Sci. USA, 92, 8891.
36. REIF K., LUCAS S. and CANTRELL D. A. (1997): A negative role for PI3K in T cell antigen receptor signalling. Curr. Biol., 7, 285-293.
37. REIF K., NOBES C. D., THOMAS G., HALL A. and CANTRELL D. A. (1996): PI3K signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol., 6, 1445-1455.
38. SCHNEIDER H., PRASAD K. V. S., SHOELSON S. and RUDD C. E. (1995): CTLA-4 binding to the lipid kinase PI3K in T cells. J. Exp. Med., 181, 351-355.
39. SHIRATORI T., MIYATAKE S., OHNO H., NAKASEKO C., ISONO K., BONIFACINO J. and SPITO T. (1997): Tyrosine phosphorylation controls internalisation of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity, 6, 583-589.
40. TAPON N. and HALL A. (1997): Rho, Rac, and Cdc42 GTPases regulate the organisation of the actin cytoskeleton. Curr. Opin. Cell Biol., 9, 86-92.
41. TRUITT K. E., NAGEL T., SUEN L. F. and IMBODEN J. B. (1996): Structural requirements for CD28-mediated costimulation of IL-2 production in Jurkat T cells. J. Immunol., 156, 4539-4541.
42. h2) immune response and altered airway responsiveness. J. Exp. Med., 185, 1671-1679.
43. TUOSTO L., MICHEL F. and ACUTO O. (1996): p95Vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med., 184, 1161-1166.
44. VANHAESEBROECK B., LEEVERS S. A., PANAYOTOU G. and WATERFIELD M. D. (1997): Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci., 22, 267-272.
45. WARD S. G. (1996): CD28: a signalling perspective. Biochem. J., 318, 361-377.
46. WARD S. G., BACON K. B. and WESTWICK J. (1998): Chemokines and T lymphocytes: more than an attraction. Immunity. 9, 1-11.
47. WARD S. G., JUNE C. H. and OLIVE D. (1996): PI3K: a pivotal pathway in T cell activation. Immunol. Today, 17, 187-197.
48. WEBB L., WALMSLEY M. J. and FELDMANN M. (1996): Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 costimulatory pathway: requirement for both B7.1 and B7.2. Eur. J. Immunol., 26, 2320-2328.
49. WINDHAGEN A., NEWCOMBE J., DANGOND C., STRAND C., WOODROOFE N., CUZNER M. L. and HAFLER D. A. (1995): Expression of costimulatory molecules B7.1 and B7.2 and IL-12 cytokine in multiple sclerosis lesions. J. Exp. Med., 182, 1985-1996.
50. WU J., MOTTO D. G., KORETZKY G. A. and WEISS A. (1996): Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity, 4, 593-602.
51. ZHOU S. Y., SHOELSON S. E., CHAUDHURI M., GISH G., PAWSON T., HASER W. G., KING F., ROBERTS T., RATNOFSKY S., LECHLEIDER R. J., NEEL B. G., BIRGE R. B., FAJARDO J. E., CHOU M. M., HANAFUSA H., SCHAFFHAUSEN B. and CANTLEY L. (1993): SH2 domains recognise specific phosphopeptide sequences. Cell, 72, 767-778.